Special items: Ovarian Cancer and Us blog best viewed in Firefox

Saturday, February 28, 2009

A phase II study of Fulvestrant in the treatment of multipy-recurrent epithelial ovarian cancer


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.